May 2014 FDA Recall Fluvastatin by Teva Pharmaceuticals Usa
D-1430-2014 - Failed Tablet/Capsule Specifications

This Class II drug recall was voluntarily initiated by Teva Pharmaceuticals Usa on May 29, 2014 for the product Fluvastatin. The FDA reported the reason for recall as failed tablet/capsule specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1430-2014

Reason for Recall
Failed Tablet/Capsule Specifications: Teva Pharmaceuticals USA, Inc. is voluntarily recalling one lot of Fluvastatin Capsules USP, 20 mg due to a customer complaint trend regarding capsule breakage.
Initiated
05-29-2014
Reported
07-16-2014
Quantity
8,472 Bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Teva Pharmaceuticals USA
Nationwide and Guam, Puerto Rico, American Samoa, Virgin Islands
Fluvastatin Capsules USP, 20 mg, Rx Only, 30-count bottle, manufactured for Teva Pharmaceuticals, Sellersville, PA, by Teva Pharmaceutical IND LTD, Jerusalem, Israel, NDC 0093-7442-56

Batch or Lot Expiration Information

Lot# : F47008, Exp. 7/2015